share_log
Reuters ·  May 29 09:33
Biohaven Shares Fall 28% as Protein-Degrader Drug Data Falls Short of Investor Expectations
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment